4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001104659-22-025736
Director bought 547,380 shares at an average $14.06 ($7,695,707)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. Director | 2022-02-17 | Purchase | +166,229 | $14.78 | $2,457,264 | 10,271,886 | I |
| RA CAPITAL MANAGEMENT, L.P. Director | 2022-02-18 | Purchase | +166,229 | $14.12 | $2,346,389 | 10,438,115 | I |
| RA CAPITAL MANAGEMENT, L.P. Director | 2022-02-22 | Purchase | +214,922 | $13.46 | $2,892,055 | 10,653,037 | I |
| Open-market purchases · 547,380 sh · avg $14.06 · $7,695,707 | |||||||
Loading xslF345X03/tm227406-1_4.xml…